Narendra K. Vaish

2.2k total citations · 1 hit paper
24 papers, 1.6k citations indexed

About

Narendra K. Vaish is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Narendra K. Vaish has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Infectious Diseases. Recurrent topics in Narendra K. Vaish's work include RNA and protein synthesis mechanisms (12 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Chemical Synthesis and Analysis (5 papers). Narendra K. Vaish is often cited by papers focused on RNA and protein synthesis mechanisms (12 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Chemical Synthesis and Analysis (5 papers). Narendra K. Vaish collaborates with scholars based in Germany, United States and India. Narendra K. Vaish's co-authors include Barry Polisky, Vasant Jadhav, K.M. Muraleedharan, Subramania Ranganathan, Narayanaswamy Jayaraman, Ian MacLachlan, Karin S. Blanchard, Lloyd B. Jeffs, Chandra Vargeese and Jennifer A. Lockridge and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Narendra K. Vaish

23 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

2005 908 citations Dylan Morrissey, Jennifer A. Lockridge et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Narendra K. Vaish

Since Specialization

Citations

This map shows the geographic impact of Narendra K. Vaish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narendra K. Vaish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narendra K. Vaish more than expected).

Fields of papers citing papers by Narendra K. Vaish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narendra K. Vaish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narendra K. Vaish. The network helps show where Narendra K. Vaish may publish in the future.

Co-authorship network of co-authors of Narendra K. Vaish

This figure shows the co-authorship network connecting the top 25 collaborators of Narendra K. Vaish. A scholar is included among the top collaborators of Narendra K. Vaish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narendra K. Vaish. Narendra K. Vaish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pilot Trial of OnabotulinumtoxinA (Botox) in Moderate to Severe Restless Legs Syndrome 2011 ·International Journal of Neuroscience ·Pinky Agarwal, (unknown), Narendra K. Vaish, (unknown)	14
2	Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs 2010 ·Nucleic Acids Research ·Narendra K. Vaish, Feng Chen, Shaguna Seth, Kathy Fosnaugh, Yan Liu, Roger Adami, Tod Brown, Yan Chen, Pierrot Harvie, Rachel Johns, (unknown), Brian Granger, Patrick Charmley, Michael E. Houston, Michael V. Templin, Barry Polisky	83
3	Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs breakdown → 2005 ·Nature Biotechnology ·Dylan Morrissey, Jennifer A. Lockridge, (unknown), Karin S. Blanchard, Kristi Jensen, (unknown), (unknown), (unknown), Susan F. Radka, Vasant Jadhav, Narendra K. Vaish, Shawn Zinnen, Chandra Vargeese, Keith Bowman, (unknown), Lloyd B. Jeffs, Adam D. Judge, Ian MacLachlan, Barry Polisky	908
4	Functional RNAs as Tools in Proteomics 2005 ·Current Proteomics ·Narendra K. Vaish, Shawn Zinnen	1
5	High-Throughput Ribozyme-Based Assays for Detection of Viral Nucleic Acids 2004 ·Chemistry & Biology ·Karl Kossen, Narendra K. Vaish, Vasant Jadhav, (unknown), Hong Wang, Robert Jenison, James A. McSwiggen, Barry Polisky, Scott D. Seiwert	17
6	Monitoring protein modification with allosteric ribozymes 2004 ·Methods ·Narendra K. Vaish, Karl Kossen, Lori Andrews, (unknown), Scott D. Seiwert	0
7	Halo- and selenolactonisation: the two major strategies for cyclofunctionalisation 2004 ·Tetrahedron ·Subramania Ranganathan, K.M. Muraleedharan, Narendra K. Vaish, Narayanaswamy Jayaraman	202
8	Zeptomole detection of a viral nucleic acid using a target-activated ribozyme 2003 ·RNA ·Narendra K. Vaish, Vasant Jadhav, Karl Kossen, (unknown), Lori Andrews, James A. McSwiggen, Barry Polisky, Scott D. Seiwert	23
9	A Novel, Modification-Dependent ATP-Binding Aptamer Selected from an RNA Library Incorporating a Cationic Functionality 2003 ·Biochemistry ·Narendra K. Vaish, (unknown), (unknown), Jack W. Szostak, Larry W. McLaughlin	59
10	Monitoring post-translational modification of proteins with allosteric ribozymes 2002 ·Nature Biotechnology ·Narendra K. Vaish, Fang Dong, Lori Andrews, Rebecca E. Schweppe, Natalie G. Ahn, Lawrence M. Blatt, Scott D. Seiwert	40
11	In vitro evolution of the hammerhead ribozyme to a purine-specific ribozyme using mutagenic PCR with two nucleotide analogues 2000 ·Journal of Molecular Biology ·Anilkumar R. Kore, Narendra K. Vaish, Jonathan Morris, Fritz Eckstein	9
12	Expanding the structural and functional diversity of RNA: analog uridine triphosphates as candidates for in vitro selection of nucleic acids 2000 ·Nucleic Acids Research ·Narendra K. Vaish	47
13	Recent developments in the hammerhead ribozyme field 1998 ·Nucleic Acids Research ·Narendra K. Vaish, Anilkumar R. Kore, F. Eckstein	60
14	The Demonstration of Spontaneous Self-assembly of Novel Fluorescent Pro flavin-Lipids 1998 ·Zenodo (CERN European Organization for Nuclear Research) ·Darshan Ranganathan, V. Haridas, Narendra K. Vaish, K. P. Madhusudanan, Raja Roy, (unknown), V. Srinivas	1
15	In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme 1998 ·Proceedings of the National Academy of Sciences ·Narendra K. Vaish, (unknown), Olga S. Fedorova, Fritz Eckstein	30
16	Isolation of Hammerhead Ribozymes with Altered Core Sequences by in Vitro Selection 1997 ·Biochemistry ·Narendra K. Vaish, (unknown), Fritz Eckstein	27
17	Structure—function studies of the hammerhead ribozyme 1997 ·Current Opinion in Chemical Biology ·Sandeep Verma, Narendra K. Vaish, Fritz Eckstein	16
18	Crystal Structure of [Aib-COCO-Aib]Cu2: A Unique Example of Modular Self-Assembly 1995 ·Journal of the American Chemical Society ·Darshan Ranganathan, Narendra K. Vaish, Gadisetti V.R. Chandramouli, Babu Varghese, Rajendra Bose Muthukumaran, P. T. Manoharan	11
19	Conformation of the oxalamide group in retro‐bispeptides 1994 ·International journal of peptide & protein research ·Isabella L. Karle, Darshan Ranganathan, Kavita Shah, Narendra K. Vaish	23
20	An exceptionally mild and efficient route to dehydroalanine peptides 1992 ·Journal of the Chemical Society Chemical Communications ·Darshan Ranganathan, Kavita Shah, Narendra K. Vaish	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact